Professor Pierre-Régis Burgel is a Professor of Pneumology at Université Paris Descartes and a Pulmonologist at Cochin Hospital, Paris, France. He is a member of the Société de Pneumologie de Langue Francaise (SPLF), European Cystic Fibrosis Society (ECFS), French Council for Cystic Fibrosis, European Respiratory Society (ERS), and American Thoracic Society (ATS). He has published a significant number of scientific papers and articles on topics such as cystic fibrosis in adults, COPD phenotypes, chronic bacterial infection in COPD, and cystic fibrosis.
Professor Burgel is on the editorial board of European Respiratory Journal, COPD Journal, and Revue Française des Maladies Respiratoires. He is an Advisor for AstraZeneca, Chiesi, Takeda, Boehringer Ingelheim, and Novartis. He is on the Speaker's Bureau of Takeda, AstraZeneca, Chiesi, Boehringer Ingelheim, and Novartis. Professor Burgel's research mainly focuses on the areas such as COPD and cystic fibrosis.